Resources

Your selections:

Clear all

Show Filters

We found 4 resources that match your search.

DAIDS Deregistration

Guidance regarding the DAIDS deregistration process.

Document Date:

DAIDS Financial Disclosure Guidance

Process for collection of financial disclosure by clinical investigators conducting DAIDS-sponsored IND trials.

Document Date:

IBC RAC Guidance

Guidance and requirements for daids-supported research involving recombinant DNA.

Document Date:

Required Documentation Based on 45 CFR 46

Required documentation of risk/benefit category and approval of clinical studies for inclusion of children by institutional review boards/ethics committees based on 45 CFR 46, Subpart D.

Document Date: